Search Results - Ron Bose
- Showing 1 - 20 results of 38
- Go to Next Page
-
1
The ErbB kinase domain: Structural perspectives into kinase activation and inhibition by Ron Bose, Xuewu Zhang
Published 2008Revisão -
2
Using Multigene Tests to Select Treatment for Early-Stage Breast Cancer by Rodrigo Gonçalves, Ron Bose
Published 2013Revisão -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Analysis of the Role of the C-Terminal Tail in the Regulation of the Epidermal Growth Factor Receptor by Erika Kovács, Rahul Das, Qi Wang, Timothy S. Collier, Aaron J. Cantor, Yongjian Huang, Kathryn Wong, Amar Mirza, Tiago Barros, Patricia Grob, Natalia Jura, Ron Bose, John Kuriyan
Published 2015Artigo -
11
-
12
Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer by Farrokh Dehdashti, Ningying Wu, Ron Bose, Michael Naughton, X. Cynthia, Bernadette Marquez‐Nostra, Philipp Diebolder, Cedric Mpoy, Buck E. Rogers, Suzanne E. Lapi, Richard Laforest, Barry A. Siegel
Published 2018Artigo -
13
[89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer by Richard Laforest, Suzanne E. Lapi, Reiko Oyama, Ron Bose, Adel Tabchy, Bernadette Marquez‐Nostra, Jennifer Burkemper, Brian D. Wright, Jennifer B. Frye, Sarah Frye, Barry A. Siegel, Farrokh Dehdashti
Published 2016Artigo -
14
Identification of Targets of c-Src Tyrosine Kinase by Chemical Complementation and Phosphoproteomics by Isabel Martinez Ferrando, Raghothama Chaerkady, Jun Zhong, Henrik Molina, Harrys K.C. Jacob, Katie Herbst-Robinson, Beverley M. Dancy, Vikram Katju, Ron Bose, Jin Zhang, Akhilesh Pandey, Philip A. Cole
Published 2012Artigo -
15
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study by John D. Hainsworth, Funda Meric‐Bernstam, Charles Swanton, Herbert I. Hurwitz, David R. Spigel, Christopher J. Sweeney, Howard A. Burris, Ron Bose, Bongin Yoo, Alisha Stein, Mary Beattie, Razelle Kurzrock
Published 2018Artigo -
16
HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment by Shyam M. Kavuri, Naveen K. Jain, Francesco Galimi, Francesca Cottino, Simonetta M. Leto, Giorgia Migliardi, Adam C. Searleman, Wei Shen, John Monsey, Livio Trusolino, Samuel A. Jacobs, Andrea Bertotti, Ron Bose
Published 2015Artigo -
17
Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer by Ron Bose, Shyam M. Kavuri, Adam C. Searleman, Wei Shen, Dong Shen, Daniel C. Koboldt, John Monsey, Nicholas Goel, Adam B. Aronson, Shunqiang Li, X. Cynthia, Li Ding, Elaine R. Mardis, Matthew J. Ellis
Published 2012Artigo -
18
Retrospective Analysis of Treatment Patterns and Effectiveness of Palbociclib and Subsequent Regimens in Metastatic Breast Cancer by Jing Xi, Amit M. Oza, Shana Thomas, Foluso O. Ademuyiwa, Katherine N. Weilbaecher, Rama Suresh, Ron Bose, Mathew Cherian, Leonel F. Hernandez‐Aya, Ashley Frith, Lindsay L. Peterson, Jingqin Luo, Jairam Krishnamurthy, X. Cynthia
Published 2019Artigo -
19
Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study by Razelle Kurzrock, Daniel W. Bowles, Hyunseok Kang, Funda Meric‐Bernstam, John D. Hainsworth, David R. Spigel, Ron Bose, Howard A. Burris, Christopher J. Sweeney, M. Beattie, Steven Blotner, Katja Schulze, Vaikunth Cuchelkar, Charles Swanton
Published 2020Artigo -
20
Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer by Ahmad Awada, Rámón Colomer, Kenichi Inoue, Igor Bondarenko, Rajendra Badwe, Georgia Demetriou, Soo Chin Lee, Ajay Mehta, Sung‐Bae Kim, Thomas Bachelot, Chanchal Goswami, Suryanarayan V.S. Deo, Ron Bose, Alvin Wong, Feng Xu, Bin Yao, Richard Bryce, Lisa A. Carey
Published 2016Artigo
Search Tools:
Related Subjects
Cancer
Breast cancer
Biology
Internal medicine
Medicine
Oncology
Trastuzumab
Cancer research
Gene
Genetics
Metastatic breast cancer
Neratinib
Biochemistry
Cell biology
Signal transduction
Mutation
Colorectal cancer
Mutant
Protein kinase A
Chemistry
Kinase
Lapatinib
Protein kinase domain
Tyrosine kinase
Cohort
ERBB3
Environmental health
Fulvestrant
Pertuzumab
Population